Amgad Shebl
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Aug 02, 2022
Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.Hillary Cuesta, Ibrahim El Menyawi, Alphonse Hubsch
|Jun 04, 2020
Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.Christopher Wallenhorst, Ami Patel, Amgad Shebl
|May 16, 2020
Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports.Amgad Shebl, Susie Gabriel, Kristy Van Dinther
Pageof 1
